Commit To Buy Madrigal Pharmaceuticals At $170, Earn 11.6% Annualized Using Options
April 04, 2024 at 11:33 AM EDT
Investors eyeing a purchase of Madrigal Pharmaceuticals Inc (MDGL) stock, but tentative about paying the going market price of $246.01/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $170 strike, which has a bid at the time of this writing of $15.50..